Britt Drögemöller

 

---- Home | Research | Publications | Funding & Awards | Volunteer | Contact ----

 

FUNDING AND AWARDS

  1. Co-investigator for CIHR Project Scheme Grant entitled Discovery, validation, and pre-clinical development of novel strategies to prevent anthracycline-induced cardiotoxicity (2017-2022)

  2. Co-principal investigator for BC Children’s Research Institute Evidence to Innovation Seed Grant entitled Genome-wide association study of L-asparaginase-induced pancreatitis in pediatric cancer (2017)

  3. Killam Postdoctoral Fellow Research Prize (2019)

  4. Canadian Society of Pharmacology and Therapeutics Postdoc Award (2018)

  5. BC Children’s Hospital Research Outstanding Achievement by a Postdoctoral Fellow (2017)

  6. CIHR Postdoctoral Fellowship for project entitled Identification of the genetic variants involved in the development of severe adverse drug reactions in cancer patients treated with cisplatin (2017-2019) 

  7. MSFHR Postdoctoral Fellowship for project entitled Unraveling the genetics of severe reactions to chemotherapy: Moving towards maximum benefit with minimal harm (2017-2018)

  8. CIHR Drug Safety and Effectiveness Cross‐Disciplinary Training (DSECT) Program for project entitled Genome-wide association study of L-asparaginase-induced pancreatitis in pediatric cancer patients (2017-2018)

  9. Child and Family Research Institute Hoffmeister fellowship for project entitled A comprehensive analysis of the genomic and clinical factors contributing to the occurrence of cisplatin-induced ototoxicity (2015-2016)

  10. Stellenbosch University New Voices in Science Finalist for presentation entitled Genetic profiling ‐ a silver bullet for schizophrenia treatment? (2014)

  11. Stellenbosch University Postdoctoral Fellowship (2014)

  12. Stellenbosch University Consolidoc Programme for project (2014)

  13. South African National Research Foundation Innovation Doctoral Scholarship for project entitled Investigation of genetic variation contributing to antipsychotic treatment response in a South African first episode schizophrenia cohort (2010-2013) 

  14. L’Oréal-UNESCO for Women in Science in Sub-Saharan Africa Fellowship for project entitled The investigation of antipsychotic pharmacogenomic traits in two South African schizophrenia cohorts (2012)           

  15. Stellenbosch University PhD Merit Bursary for project entitled Investigation of genetic variation contributing to antipsychotic treatment response in a South African first episode schizophrenia cohort (2010-2012)    

  16. Harry Crossley Foundation Bursary for project entitled Detection of sequence diversity in the CYP2C19 gene of Xhosa South African individuals: An analytical and comparative study including in silico and functional analysis of the 5’ flanking region (2008-2009)   

  17. Stellenbosch University Faculty of Health Sciences’ Annual Academic Day 
    Young Researcher Winning Oral Presentation (Category <35 years) for presentation entitled CYP2C19 sequence diversity: A missing ingredient in the optimal treatment plans of South African individuals (2009)      

  18. South African National Research Foundation Grant-Holder Bursary for project entitled Detection of sequence diversity in the CYP2C19 gene of Xhosa South African individuals: An analytical and comparative study including in silico and functional analysis of the 5’ flanking region (2008)   

  19. South African National Research Foundation Prestige Programme for project entitled Detection of sequence diversity in the CYP2C19 gene of Xhosa South African individuals: An analytical and comparative study including in silico and functional analysis of the 5’ flanking region (2007)   

  20. Stellenbosch University Honours Merit Bursary for project entitled Identification of genetic variants in the promoter region and exons 1-4 of the CYP2C19 gene in Xhosa individuals (2007) 

  21. Stellenbosch University Undergraduate Merit Bursary (2004)